Showing 3481-3490 of 5910 results for "".
- Amazon Enters Health-Tracking Space With Halo Wristband, App Debuthttps://modernod.com/news/amazon-enters-health-tracking-space-with-halo-wristband-app-debut/2478213/Amazon introduced Halo on Thursday, a subscription service that uses an app and wristband to monitor an individual’s overall health and wellness, including activity, sleep and body fat, as well as tone of voice to analyze emotional well-being. “We are using Amazo
- AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Programhttps://modernod.com/news/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical-development-of-its-xlrp-gene-therapy-program/2478200/Applied Genetic Technologies Corporation (AGTC) announced that preclinical data validating the transgene (hRPGRco) that is being evaluated in the company’s ongoing phase 1/2 clinical trial in patients with X-lined retinitis pigmentosa (XLRP) have been published in the July 15, 2020 print issue of
- EU Wraps Up Advanced Talks With Moderna for COVID-19 Vaccine Supply Dealhttps://modernod.com/news/eu-wraps-up-advanced-talks-with-moderna-for-covid-19-vaccine-supply-deal/2478195/The European Commission said Monday that it concluded exploratory talks with Moderna for an initial purchase of 80 million doses of the company’s mRNA vaccine candidate against SARS-CoV-2. The contractual framework would also provide an option for EU member states to purchase an additional
- Supreme Court to Hear Arguments on Pivotal Case That Decides Fate of ACA After Electionhttps://modernod.com/news/supreme-court-to-hear-arguments-on-pivotal-case-that-decides-fate-of-aca-after-election/2478180/The Supreme Court will hear oral arguments in a lawsuit over the constitutionality of the Affordable Care Act (ACA) on November 10, a week after the presidential election, according to a FierceHealthcare
- How COVID-19 is Shaking Up Medical Education—For Goodhttps://modernod.com/news/how-covid-19-is-shaking-up-medical-education-for-good/2478168/With COVID-19 shows no signs of letting up soon, leaders at medical schools are adapting their plans for education in the fall to meet the new demands of the pandemic, according to a FierceHealthcare report. That means going digital in an unprecedented way—both in terms of classe
- TearClear Raises $22M in Series B Fundinghttps://modernod.com/news/tearclear-raises-22m-in-series-b-funding/2478158/TearClear announced it has raised $22 million in a Series B funding round. The company intends to use the funds to advance multiple clinical programs in development, with two lead candidates in glaucoma paving the way for future indications. Led by Chief Executive Officer Robert Dempsey, T
- CooperVision Acquires GP Specialists, Expanding Specialty EyeCare Business and Ortho-K Optionshttps://modernod.com/news/coopervision-acquires-gp-specialists-expanding-specialty-eyecare-business-and-ortho-k-options/2478137/CooperVision has acquired C&E GP Specialists, a customized orthokeratology contact lens manufacturer and distributor. The move expands CooperVision’s Specialty eye care business. Terms of the deal were not disclosed. “CooperVision is committed to providing eye care professionals
- AAO: Planned Medicare Cuts Deal Heavy Blow to Nation’s Ophthalmologistshttps://modernod.com/news/aao-planned-medicare-cuts-deal-heavy-blow-to-nations-ophthalmologists/2478132/The American Academy of Ophthalmology (AAO) released a statement opposing the Centers for Medicare & Medicaid Services (CMS) proposed annual Physician Fee Schedule and Quality Payment Program
- Some Providers Face Daunting Repayment Deadline for Medicare Advance Loanshttps://modernod.com/news/some-providers-face-daunting-repayment-deadline-for-medicare-advance-loans/2478108/Starting this month, some providers are facing the prospect of their Medicare payments garnished to repay COVID-19 loans, according to a FierceHealthcare
- Pfizer, BioNTech Begin Phase 2/3 Coronavirus Vaccine Studyhttps://modernod.com/news/pfizer-biontech-pick-bnt162b2-to-advance-into-phase-2-3-coronavirus-vaccine-study/2478084/Pfizer and partner BioNTech said they have decided to advance the nucleoside-modified mRNA vaccine candidate BNT162b2 into phase 2/3 testing. The vaccine, to be trialed at the 30-mcg dose as part of a two-dose regimen, encodes for an optimized SARS-CoV-2 full-length spike glycoprotein, which the